- Experts: Ending adequate provision would shut down prescription drug ads<p>The US Food and Drug Administration’s (FDA) plans to eliminate adequate provision in direct-to-consumer (DTC) prescription drug ads could result in a de facto ban on drug advertising due to the…raps · 8d ago↗ source
- Industry wants more clarity on NGS for assessing gene therapy safety<p>The pharmaceutical industry has largely endorsed the US Food and Drug Administration's (FDA) guidance on next-generation sequencing (NGS) for assessing the safety of human gene therapy products.…raps · 8d ago↗ source
- This Week at FDA: FDA staff raise concerns about peptide conflicts, top Democrat wants DOGE investigation, and more<p>Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This…